Morbidity risks among older adults with pre-existing age-related diseases

Experimental Gerontology

Volumn 48, Issue 12, 2013, Pages 1395-1401

  Akushevich, Igor ^a   Kravchenko, Julia ^b   Ukraintseva, Svetlana ^a   Arbeev, Konstantin ^a   Kulminski, Alexander ^a   Yashin, Anatoliy I ^a  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; Chronic disease onset; Comorbidity; Dependent risks; Geriatric disease; Medicare

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; FEMALE; GERIATRIC DISORDER; HUMAN; KIDNEY CANCER; KIDNEY FAILURE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL SERVICE; MEDICARE; MELANOMA; MORBIDITY; PANCREAS CANCER; PARKINSON DISEASE; PRIORITY JOURNAL; ULCER; UNITED STATES;

AGING; CHRONIC DISEASE ONSET; COMORBIDITY; DEPENDENT RISKS; GERIATRIC DISEASE; MEDICARE;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CHRONIC DISEASE; COMORBIDITY; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INCIDENCE; MALE; MEDICARE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; TIME FACTORS; UNITED STATES;

EID: 84884942914     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2013.09.005     Document Type: Article

References (50)

1. Akushevich I., Kravchenko J., Ukraintseva S., Arbeev K., Yashin A.I. Age patterns of incidence of geriatric disease in the U.S. elderly population: Medicare-based analysis. J. Am. Geriatr. Soc. 2012, 60(2):323-327.
2. Anderson G., Solutions J.H.U.P.f, Foundation R.W.J. Chronic conditions: making the case for ongoing care 2004, Johns Hopkins University.
3. Atchison E.A., Gridley G., Carreon J.D., Leitzmann M.F., McGlynn K.A. Risk of cancer in a large cohort of US veterans with diabetes. Int. J. Cancer 2011, 128(3):635-643.
4. Boffetta P., Ye W., Boman G., Nyren O. Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden. Eur. Respir. J. 2002, 19(1):127-133.
5. Cann S.A., van Netten J.P., van Netten C. Hypothesis: iodine, selenium and the development of breast cancer. Cancer Causes Control 2000, 11(2):121-127.
6. Chasman D., Kozlowski P., Zee R., Kwiatkowski D., Ridker P. Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein. Genes Immun. 2006, 7(3):211-219.
7. Cibere J., Sibley J., Haga M. Rheumatoid arthritis and the risk of malignancy. Arthritis Rheum. 2005, 40(9):1580-1586.
8. Coughlin S.S., Giovannucci E.L. Diabetes and cancer. Diab. Chron. Complications 2012, 294.
9. Driver J.A., Beiser A., Au R., Kreger B.E., Splansky G.L., Kurth T., et al. Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study. BMJ 2012, 344.
10. Farrow D., Davis S. Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int. J. Cancer 1990, 45(5):816-820.
11. Fiala K.H., Whetteckey J., Manyam B.V. Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?. Parkinsonism Relat. Disord. 2003, 9(6):321-327.
12. Flood A., Strayer L., Schairer C., Schatzkin A. Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control 2010, 21(8):1277-1284.
13. Friedman G.D., Coates A.O., Potter J.D., Slattery M.L. Drugs and colon cancer. Pharmacoepidemiol. Drug Saf. 1998, 7(2):99-106.
14. Fuhrman B.J., Schairer C., Gail M.H., Boyd-Morin J., Xu X., Sue L.Y., et al. Estrogen metabolism and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst. 2012, 104(4):326-339.
15. Hannan M.T., Felson D.T., Dawson-Hughes B., Tucker K.L., Cupples L.A., Wilson P.W., et al. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J. Bone Miner. Res. 2010, 15(4):710-720.
16. Heyman A., Wilkinson W.E., Stafford J.A., Helms M.J., Sigmon A.H., Weinberg T. Alzheimer's disease: a study of epidemiological aspects. Ann. Neurol. 2004, 15(4):335-341.
17. Hidalgo C.A., Blumm N., Barabási A.L., Christakis N.A. A dynamic network approach for the study of human phenotypes. PLoS Comput. Biol. 2009, 5(4):e1000353.
18. Ilveskoski E., Perola M., Lehtimäki T., Laippala P., Savolainen V., Pajarinen J., et al. Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study. Circulation 1999, 100(6):608-613.
19. Karim R., Dell R.M., Greene D.F., Mack W.J., Gallagher J.C., Hodis H.N. Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization. Menopause 2011, 18(11):1172.
20. Kasper J.S., Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol. Biomark. Prev. 2006, 15(11):2056-2062.
21. Koukourakis M.I., Kambouromiti G., Pitsiava D., Tsousou P., Tsiarkatsi M., Kartalis G. Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication. Inflammation 2009, 32(3):169-175.
22. Kulminski A.M., Culminskaya I., Ukraintseva S.V., Arbeev K.G., Arbeeva L., Wu D., et al. Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan. Aging Cell 2011, 10(3):533-541.
23. Kulminski A.M., Culminskaya I., Arbeev K.G., Ukraintseva S.V., Stallard E., Arbeeva L., et al. The role of lipid-related genes, aging-related processes, and environment in healthspan. Aging Cell 2013, 12(2):237-246.
24. Li Y., Grupe A., Rowland C., Holmans P., Segurado R., Abraham R., et al. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Hum. Mol. Genet. 2008, 17(5):759-767.
25. NIH/NHLBI Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases Retrieved June, 2010, from. http://www.nhlbi.nih.gov/resources/docs/06a_ip_chtbk.pdf.
26. Nikiteas N.I., Tzanakis N., Gazouli M., Rallis G., Daniilidis K., Theodoropoulos G., et al. Serum IL-6, TNFa and CRP levels in Greek colorectal cancer patients: prognostic implications. World J. Gastroenterol. 2005, 11:1639-1643.
27. Ou S.-M., Lee Y.-J., Hu Y.-W., Liu C.-J., Chen T.-J., Fuh J.-L., et al. Does Alzheimer's disease protect against cancers? A nationwide population-based study. Neuroepidemiology 2012, 40(1):42-49.
28. Panelos J., Massi D. Emerging role of notch signaling in epidermal differentiation and skin cancer. Cancer Biol. Ther. 2009, 8(21):1986-1993.
29. Pankratz N., Byder L., Halter C., Rudolph A., Shults C.W., Conneally P.M., et al. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Mov. Disord. 2006, 21(1):45-49.
30. Rajpathak S.N., Kumbhani D.J., Crandall J., Barzilai N., Alderman M., Ridker P.M. Statin therapy and risk of developing type 2 diabetes: a meta-analysis. Diabetes Care 2009, 32(10):1924-1929.
31. Rod N.H., Hansen A.M., Nielsen J., Schnohr P., Grønbæk M. Low-risk factor profile, estrogen levels, and breast cancer risk among postmenopausal women. Int. J. Cancer 2009, 124(8):1935-1940.
32. Rubin R.R., Ma Y., Marrero D.G., Peyrot M., Barrett-Connor E.L., Kahn S.E., et al. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 2008, 31(3):420-426.
33. Santillan A.A., Camargo C.A., Colditz G.A. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control 2003, 14(4):327-334.
34. Simon M.S., Tang M.-T.C., Bernstein L., Norman S.A., Weiss L., Burkman R.T., et al. Do thyroid disorders increase the risk of breast cancer?. Cancer Epidemiol. Biomark. Prev. 2002, 11(12):1574-1578.
35. Sivakumaran S., Agakov F., Theodoratou E., Prendergast J.G., Zgaga L., Manolio T., et al. Abundant pleiotropy in human complex diseases and traits. Am. J. Hum. Genet. 2011, 89(5):607-618.
36. Solomon D.H., Massarotti E., Garg R., Liu J., Canning C., Schneeweiss S. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA 2011, 305(24):2525.
37. Szekely C.A., Thorne J.E., Zandi P.P., Ek M., Messias E., Breitner J.C., et al. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 2004, 23(4):159-169.
38. Tabarés-Seisdedos R., Dumont N., Baudot A., Valderas J.M., Climent J., Valencia A., et al. No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. Lancet Oncol. 2011, 12(6):604-608.
39. Thomas E., Brewster D.H., Black R.J., Macfarlane G.J. Risk of malignancy among patients with rheumatic conditions. Int. J. Cancer 2000, 88(3):497-502.
40. Tosovic A., Bondeson A.-G., Bondeson L., Ericsson U.-B., Malm J., Manjer J. Research article prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women 2010.
41. Turner M.C., Chen Y., Krewski D., Ghadirian P., Thun M.J., Calle E.E. Cancer mortality among US men and women with asthma and hay fever. Am. J. Epidemiol. 2005, 162(3):212-221.
42. Ukraintseva S.V., Yashin A.I. Individual aging and cancer risk: how are they related. Demogr. Res. 2003, 9(8):163-196.
43. Ukraintseva S.V., Arbeev K.G., Akushevich I., Kulminski A., Arbeeva L., Culminskaya I., et al. Trade-offs between cancer and other diseases: do they exist and influence longevity? [Research Support, N.I.H., Extramural]. Rejuvenation Res. 2010, 13(4):387-396.
44. van Heemst D., Mooijaart S.P., Beekman M., Schreuder J., de Craen A.J.M., Brandt B.W., et al. Variation in the human TP53 gene affects old age survival and cancer mortality. Exp. Gerontol. 2005, 40(1):11-15.
45. Wang F., Gupta S., Holly E.A. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol. Biomark. Prev. 2006, 15(8):1458-1463.
46. Yang Y.X., Hennessy S., Lewis J.D. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004, 127:1044-1050.
47. Yashin A.I., Manton K.G., Stallard E. Dependent competing risks: a stochastic process model. J. Math. Biol. 1986, 24(2):119-140.
48. Yashin A.I., Ukraintseva S.V., Akushevich I.V., Arbeev K.G., Kulminski A., Akushevich L. Trade-off between cancer and aging: what role do other diseases play?: Evidence from experimental and human population studies. Mech. Ageing Dev. 2009, 130(1):98-104.
49. Yashin A., Akushevich I., Ukraintseva S., Akushevich L., Arbeev K., Kulminski A. Trends in survival and recovery from stroke: evidence from the national long-term care survey/Medicare data. Stroke 2010, 41(3):563-565.
50. Zanetti R., Loria D., Rosso S. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature. Melanoma Res. 2006, 16(3):201-206.